Literature DB >> 24795109

The role of nitric oxide on visual-evoked potentials in MPTP-induced Parkinsonism in mice.

Sinem Aras1, Gamze Tanriover2, Mutay Aslan3, Piraye Yargicoglu4, Aysel Agar5.   

Abstract

The present study aimed to elucidate visual evoked potentials (VEP) changes in MPTP induced Parkinson's disease (PD) and investigate the possible benefical effects of neuronal (n) and inducible (i) nitric oxide synthase (NOS) inhibitors on altered VEPs, lipid peroxidation and apoptosis. 3 months old C57BL/6 mice were randomly divided into 6 groups which included control (C), 7-nitra indazole treated (7-NI), S-methylisothiourea (SMT) treated, 1,2,3,6-tetrahydropyridine (MPTP) treated, 7-NI+MPTP treated and SMT+MPTP treated. Motor activity of mice was evaluated via the pole test. At the end of the experimental period VEPs were recorded, brain and retina tissues were removed for biochemical analysis. Dopaminergic neuron death at substantia nigra (SN) was determined by immunohistochemical analysis of tyrosine hydroxylase (TH). Immunohistochemical staining was also performed to determine iNOS and nNOS in all tissue sections. Mice with experimental PD exhibited decreased motor activity. Dopaminergic cell death at pars compacta of SN (SNpc) was significantly increased in MPTP treated group compared to control. Diminished Parkinsonism symptoms were observed in 7-NI+MPTP and SMT+MPTP groups. Treatment with 7-NI and SMT decreased dopaminergic cell death in MPTP treated mice. Caspase-3 activity, nitrite/nitrate and 4-hydroxynonenal (4-HNE) levels were significantly increased in SN of MPTP treated mice compared to control. Treatment with 7-NI and SMT significantly decreased elevated caspase-3 activity, nitrite/nitrate and 4-HNE levels in SN of MPTP treated mice. No significant difference in above parameters were observed in the retina. VEP latencies were significantly prolonged in MPTP group compared to control group. 7-NI and SMT treatment caused a significant decrease in VEP latencies in MPTP treated mice compared to none treated MPTP group. This data shows that 7-NI and SMT improves prolonged VEP latencies. The protective effects of 7-NI and SMT on VEP alterations can be related to decreased dopaminergic cell death and reduced lipid peroxidation.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  MPTP; Parkinson; VEPs; iNOS; nNOS

Mesh:

Substances:

Year:  2014        PMID: 24795109     DOI: 10.1016/j.neuint.2014.04.014

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  12 in total

1.  Early Postnatal Exposure to Paraquat and Maneb in Mice Increases Nigrostriatal Dopaminergic Susceptibility to a Re-challenge with the Same Pesticides at Adulthood: Implications for Parkinson's Disease.

Authors:  Dirleise Colle; Danúbia Bonfanti Santos; Aline Aita Naime; Cinara Ludvig Gonçalves; Heloisa Ghizoni; Mariana Appel Hort; Marcelo Farina
Journal:  Neurotox Res       Date:  2019-08-17       Impact factor: 3.911

2.  Semi-invasive and non-invasive recording of visual evoked potentials in mice.

Authors:  Silvia Marenna; Valerio Castoldi; Raffaele d'Isa; Cursi Marco; Giancarlo Comi; Letizia Leocani
Journal:  Doc Ophthalmol       Date:  2019-03-06       Impact factor: 2.379

Review 3.  Nitric oxide modulation in neuroinflammation and the role of mesenchymal stem cells.

Authors:  Pan M Liy; Nur Nabilah A Puzi; Shinsmon Jose; Sharmili Vidyadaran
Journal:  Exp Biol Med (Maywood)       Date:  2021-03-09

4.  Chronic Progressive Neurodegeneration in a Transgenic Mouse Model of Prion Disease.

Authors:  Nina Fainstein; Dvir Dori; Kati Frid; Alexa T Fritz; Ilona Shapiro; Ruth Gabizon; Tamir Ben-Hur
Journal:  Front Neurosci       Date:  2016-11-11       Impact factor: 4.677

5.  Recombinant Adeno-Associated Virus-mediated rescue of function in a mouse model of Dopamine Transporter Deficiency Syndrome.

Authors:  P Illiano; C E Bass; L Fichera; L Mus; E A Budygin; T D Sotnikova; D Leo; S Espinoza; R R Gainetdinov
Journal:  Sci Rep       Date:  2017-04-18       Impact factor: 4.379

6.  Treatment Of Magnesium-L-Threonate Elevates The Magnesium Level In The Cerebrospinal Fluid And Attenuates Motor Deficits And Dopamine Neuron Loss In A Mouse Model Of Parkinson's disease.

Authors:  Yanling Shen; Ling Dai; Haibo Tian; Runnan Xu; Fuying Li; Zhuohang Li; Jeremy Zhou; Liping Wang; Jianghui Dong; Liyuan Sun
Journal:  Neuropsychiatr Dis Treat       Date:  2019-11-11       Impact factor: 2.570

7.  Functional evolution of visual involvement in experimental autoimmune encephalomyelitis.

Authors:  Silvia Marenna; Su-Chun Huang; Valerio Castoldi; Raffaele d'Isa; Gloria Dalla Costa; Giancarlo Comi; Letizia Leocani
Journal:  Mult Scler J Exp Transl Clin       Date:  2020-10-28

8.  Visual evoked potentials of Niemann-Pick type C1 mice reveal an impairment of the visual pathway that is rescued by 2-hydroxypropyl-ß-cyclodextrin.

Authors:  Giampiero Palladino; Stefano Loizzo; Andrea Fortuna; Sonia Canterini; Fioretta Palombi; Robert P Erickson; Franco Mangia; Maria Teresa Fiorenza
Journal:  Orphanet J Rare Dis       Date:  2015-10-12       Impact factor: 4.123

Review 9.  Redox Imbalance and Viral Infections in Neurodegenerative Diseases.

Authors:  Dolores Limongi; Sara Baldelli
Journal:  Oxid Med Cell Longev       Date:  2016-03-27       Impact factor: 6.543

10.  Classification of Parkinson's Disease Genotypes in Drosophila Using Spatiotemporal Profiling of Vision.

Authors:  Ryan J H West; Christopher J H Elliott; Alex R Wade
Journal:  Sci Rep       Date:  2015-11-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.